. 2018 Jan 3;9(18):14124–14137. doi: 10.18632/oncotarget.23897

Table 1. Determination of IC₅₀ in MCF7 and MCF7/ADR cells.

Anticancer drugs/IC₅₀	MCF7 μM	MCF7/ADR μM	Resistant fold
Adriamycin	58.16	293.53	5.05
Adriamycin and JNJ (50 nM)	36.75	385.58	10.49
IC₅₀ Promotion rate	−36.81%	31.36%

ADR, Adriamycin. Concentration gradient of ADR for MTT is 0.03448, 0.3448, 3.448, 34.48, 103.448, 344.8, 689.65, 1379.31 μM IC₅₀ Promotion rate % = (Adriamycin + JNJ(50nM)) group IC₅₀value – Adriamycin group IC₅₀value)*100%/Adriamycin group IC₅₀value. Resistant fold = MCF7/ADR cells IC₅₀value/ MCF7 cells IC₅₀value.

Table 1. Determination of IC50 in MCF7 and MCF7/ADR cells.

Table 1. Determination of IC₅₀ in MCF7 and MCF7/ADR cells.